Intech Investment Management LLC Sells 25,324 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Intech Investment Management LLC lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 77.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 7,581 shares of the company's stock after selling 25,324 shares during the period. Intech Investment Management LLC's holdings in Henry Schein were worth $525,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Olstein Capital Management L.P. increased its holdings in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after purchasing an additional 16,000 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Henry Schein in the third quarter worth about $515,000. Private Management Group Inc. raised its position in shares of Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after acquiring an additional 18,882 shares in the last quarter. Equitable Trust Co. purchased a new stake in Henry Schein during the fourth quarter valued at approximately $417,000. Finally, Savant Capital LLC grew its stake in shares of Henry Schein by 43.9% during the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after acquiring an additional 1,420 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Insider Activity at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of research firms have issued reports on HSIC. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target on the stock. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Barrington Research reissued an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Finally, Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 target price on the stock. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $81.10.

Henry Schein Trading Down 1.1 %

NASDAQ:HSIC traded down $0.78 during trading hours on Friday, reaching $68.62. 1,028,798 shares of the company were exchanged, compared to its average volume of 1,571,105. The firm has a market cap of $8.52 billion, a price-to-earnings ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a 50 day simple moving average of $74.62 and a 200 day simple moving average of $72.60. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter in the prior year, the firm earned $0.66 earnings per share. Henry Schein's quarterly revenue was up 5.8% compared to the same quarter last year. As a group, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.